This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024
December 15 - 18, 2024
Marriott Marquis San Diego,
Live In-Person Event: December 15 - 18, 2024


Antibody Engineering & Therapeutics US 2023 as been created in conjunction with leading experts and scientists from across the Antibody community.

Take a look at the advisory board to see who played a part in this year's schedule.

The 2023 Advisory Board

  • Gregory Adams, Ph.D., Chief Scientific Officer, Elucida Oncology
  • Andrew Bradbury, M.D., Ph.D., Chief Scientific Officer, Specifica
  • Jean-Philippe Bürckert, Ph.D., Director of Informatics, Charles River Laboratories
  • Dennis R. Burton, Ph.D., Professor, Department of Immunology and Microbiology, The Scripps Research Institute
  • Kerry A. Chester, Ph.D., Professor of Molecular Medicine, UCL Cancer Institute, University College London, United Kingdom
  • Jennifer Cochran, Ph.D., Professor and Department Chair of Bioengineering, StanfordUniversity
  • Katherine Harris, Ph.D., Vice President, Discovery, Amgen
  • Mitchell Ho, Ph.D., Senior Investigator, Laboratory of Molecular Biology, NIH NCI
  • James Larrick, M.D., Ph.D., Managing Director and Chief Medical Officer, Panorama Research Institute and Velocity Pharmaceutical Development
  • Paul W.H.I. Parren, Ph.D., Professor, Department of Immunohematology and Blood Transfusion, Leiden University Medical Center and EVP and Head of R&D, Lava Therapeutics, The Netherlands
  • Andreas Plückthun, Ph.D., Professor and Director, Department of Biochemistry, University of Zürich, Switzerland
  • Nina Luning Prak, M.D., Ph.D., Professor of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania
  • Sai Reddy, Ph.D., Associate Professor, Department of Biosystems Science and Engineering, ETH Zurich/Swiss Federal Institute of Technology, Switzerland
  • Janice M. Reichert, Ph.D., Executive Director, The Antibody Society; Editor-in-Chief, mAbs; Managing Director, Reichert Biotechnology Consulting LLC
  • Janine Schuurman, Ph.D., Antibody Industry Expert and Board Member, The Antibody Society, The Netherlands
  • Jonathan Sockolosky, Ph.D., Director, Company Value Creation, Curie.Bio
  • Sally Ward, Ph.D., Professor and Director, University of Southampton, United Kingdom
  • K. Dane Wittrup, Ph.D., C.P. Dubbs Professor of Chemical Engineering and Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology